Unilife has initiated a 24/7 manufacturing cycle at its facility at Lewisberry, Pennsylvania, US after it received marketing clearance for its Unitract 1ml insulin syringes from the US FDA.
Avid Bioservices and Halozyme Therapeutics have expanded their relationship, adding manufacturing agreements and designating the CMO as a preferred supplier.
Contract research organisation (CRO) Ricerca Biosciences has entered into a business development deal with Japan-based Life Science Partner (LSP) to help penetrate the Asian market.
Almac has launched an online tool that allows trial sponsors to view, trace and amend trial material labels from anywhere in the world which, it claims, will improve and accelerate the approval process.
France-based CRO Cellvax has moved to a new laboratory to provide clients with large animal services and new technical platforms, such as scintigraphy, histological analysis and biomarkers.
Sanofi-Aventis says French manufacturing operations will focus on vaccine and biotech drugs, unveiling €150m ($202m) plan to shift emphasis away from synthetic chemistry-based production.
Hyde Engineering + Consulting has opened an office in Dublin, Ireland, enhancing its ability to provide Europe-based biopharm with compliance, qualification and automation services.
Datatrak recorded a $1.9m (€1.4m) operating loss in 2009, and revenue declined by 31 per cent, but believes measures it has taken have laid the foundation for the coming year.
A new nano-based coating that is claimed to reduce packaging waste is initially being targeted at the pharmaceutical sector but could be used in chocolate packaging as well, claims the VTT Technical Research Centre of Finland
The Klockner Pentaplast Group has invested $37m (€27m) to expand PVC production capacity and add shrink-label film capabilities at its facilities in Thailand and the US.
The FDA’s draft guidance on adaptive design in clinical trials is a balanced, practical publication, according to the EVP of a CRO who expects the document to generate a “robust discussion”.
The market for “nano-enabled” pharmaceutical packaging is growing 16.5 per cent a year and will be worth $8.1bn (€6bn) by 2014 according to new research by iRAP.
Aluminium foil as a packaging solution is marking its centenary in 2010. Stefan Glimm, executive director of the European Aluminium Foil Association (EAFA), reflects on how this packing mainstay continues to build on its ability to provide the highest...
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Epizyme, Pregis, SixLog, Anthera and Cordis.
The WHO has published its views on the production of starting materials in draft guidance which details recommendations to ensure product quality while keeping costs down.
AniClin Preclinical Services has formed a strategic alliance with Taylor Technology, a subsidiary of PharmaNet, to offer clients complete pharmacokinetic (PK) studies in fewer than five days.
The European Medicines Agency (EMA) has recommended a recall of Acino’s generic Plavix (clopidogrel bisulfate) because of alleged failings in GMP at the API production facility.
Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs.
A joint enforcement operation in the US has led to the arrests of two people accused of being involved in supplying counterfeit weight loss medication, including GSK’s Alli (orlistat).
RXi Pharmaceuticals has applied its sd-rxRNA to dermal cells, establishing the efficacy of the technology as it seeks to move it on to the next stage of development, a company VP told in-PharmaTechnologist.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at DPT, PPD, Catalent and INC Research.
Access to Millipore’s UCOE expression technology though a new partnership is “step change” for customers, says contract manufacturing organization (CMO) Eden Biodesign.
The UK budget was “a missed opportunity” to encourage manufacturing, according to UK Chemical Industries Association (CIA), but was free from unexpected tax increases.
Clinical trials that finish early due to positive treatment effects often have misleading findings, according to a journal paper which recommends researchers resist pressures to end studies prematurely.
Contract manufacturing organization (CMO) ScinoPharm says strong anticancer API sales and growing demand in Europe and Asia were key to record performance in 2009.
PPD has added capabilities at the facility acquired from Merck & Co and improved integration of other sites to create its Vaccines & Biologics Center of Excellence, a single provider of multiple laboratory services.
Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions.
The increasing incidence of chronic and “lifestyle” related disorders will fuel demand for inhalable delivery technologies over the next five years, according to a Global Industry Analysts (GIA) report.
Novozymes Biopharma has published data demonstrating the ability of Recombumin, an excipient, to protect against aggregation, oxidation and non-specific adsorption.
BioStorage Technologies has allied with Biomatrica to offer clients the option to store biological samples at room temperature, which reduces costs and energy use while maintaining stability.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a reshuffle at PhRMA and manoeuvring of directors at OSI Pharmaceuticals and Biogen Idec.
The IPEA's issuance of good manufacturing practice (GMP) “certification” is mark of manufacturing quality, says US specialty chemicals supplier W R Grace & Co.
IRL and Epichem have entered into a strategic alliance to provide the Australasian pharma market with services from drug discovery through to cGMP production.
Outsourcing-Pharma presents its latest round up of movements in the pharma sector, including appointments at Quintiles, PharmaNet, IGI Laboratories and Sentrx.
GSK has confirmed that material from the PCV1 virus has been detected in Rotarix and, although there is no evidence of a safety risk, the FDA has recommended use is temporarily suspended.
Industrial glass maker Schott ended a “rather difficult” fiscal 2009 with a loss but says rise in drug packaging sales will help drive double-digit earnings growth in current financial year.
New specialist development and manufacturing “centres of excellence” increase efficiencies and customer access to expertise, DPT Laboratories spokesman tells Outsourcing-pharma.
Dr Reddy’s has made a “significant investment” in an mPEG alcohol production facility in Mexico to strengthen its presence in a sector it believes is on the rise.
Industrial filtration specialist Pall and testing firm Sotax say their new co-marketing deal is only first stage of planned pharmaceutical industry certification solutions partnership.
